Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1994 2
1995 1
1996 1
1997 2
1998 9
1999 4
2000 2
2001 6
2002 13
2003 10
2004 12
2005 10
2006 9
2007 13
2008 9
2009 16
2010 21
2011 22
2012 26
2013 18
2014 16
2015 21
2016 21
2017 16
2018 13
2019 12
2020 18
2021 16
2022 16
2023 23
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

347 results

Results by year

Filters applied: . Clear all
Page 1
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, Coukos G, Demaria S, Deutsch E, Draganov D, Edelson RL, Formenti SC, Fucikova J, Gabriele L, Gaipl US, Gameiro SR, Garg AD, Golden E, Han J, Harrington KJ, Hemminki A, Hodge JW, Hossain DMS, Illidge T, Karin M, Kaufman HL, Kepp O, Kroemer G, Lasarte JJ, Loi S, Lotze MT, Manic G, Merghoub T, Melcher AA, Mossman KL, Prosper F, Rekdal Ø, Rescigno M, Riganti C, Sistigu A, Smyth MJ, Spisek R, Stagg J, Strauss BE, Tang D, Tatsuno K, van Gool SW, Vandenabeele P, Yamazaki T, Zamarin D, Zitvogel L, Cesano A, Marincola FM. Galluzzi L, et al. Among authors: hemminki a. J Immunother Cancer. 2020 Mar;8(1):e000337. doi: 10.1136/jitc-2019-000337. J Immunother Cancer. 2020. PMID: 32209603 Free PMC article. Review.
Oncolytic viruses for cancer immunotherapy.
Hemminki O, Dos Santos JM, Hemminki A. Hemminki O, et al. Among authors: hemminki a. J Hematol Oncol. 2020 Jun 29;13(1):84. doi: 10.1186/s13045-020-00922-1. J Hematol Oncol. 2020. PMID: 32600470 Free PMC article. Review.
Metastatic sites and survival in lung cancer.
Riihimäki M, Hemminki A, Fallah M, Thomsen H, Sundquist K, Sundquist J, Hemminki K. Riihimäki M, et al. Among authors: hemminki a. Lung Cancer. 2014 Oct;86(1):78-84. doi: 10.1016/j.lungcan.2014.07.020. Epub 2014 Aug 2. Lung Cancer. 2014. PMID: 25130083
Patterns of metastasis in colon and rectal cancer.
Riihimäki M, Hemminki A, Sundquist J, Hemminki K. Riihimäki M, et al. Among authors: hemminki a. Sci Rep. 2016 Jul 15;6:29765. doi: 10.1038/srep29765. Sci Rep. 2016. PMID: 27416752 Free PMC article.
2-Weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial.
Kellokumpu-Lehtinen PL, Harmenberg U, Joensuu T, McDermott R, Hervonen P, Ginman C, Luukkaa M, Nyandoto P, Hemminki A, Nilsson S, McCaffrey J, Asola R, Turpeenniemi-Hujanen T, Laestadius F, Tasmuth T, Sandberg K, Keane M, Lehtinen I, Luukkaala T, Joensuu H; PROSTY study group. Kellokumpu-Lehtinen PL, et al. Among authors: hemminki a. Lancet Oncol. 2013 Feb;14(2):117-24. doi: 10.1016/S1470-2045(12)70537-5. Epub 2013 Jan 4. Lancet Oncol. 2013. PMID: 23294853 Clinical Trial.
TILT Biotherapeutics.
Hemminki A. Hemminki A. Hum Vaccin Immunother. 2017 May 4;13(5):970-971. doi: 10.1080/21645515.2017.1298962. Epub 2017 Mar 1. Hum Vaccin Immunother. 2017. PMID: 28384050 Free PMC article. No abstract available.
Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy.
Wang H, Borlongan M, Hemminki A, Basnet S, Sah N, Kaufman HL, Rabkin SD, Saha D. Wang H, et al. Among authors: hemminki a. Hum Gene Ther. 2023 Sep;34(17-18):878-895. doi: 10.1089/hum.2023.099. Hum Gene Ther. 2023. PMID: 37578106 Free PMC article. Review.
Oncolytic adenovirus for treatment of malignant ascites.
Hemminki A, Heiniö C. Hemminki A, et al. Mol Ther Oncolytics. 2022 Aug 14;26:302-303. doi: 10.1016/j.omto.2022.07.010. eCollection 2022 Sep 15. Mol Ther Oncolytics. 2022. PMID: 36032634 Free PMC article. No abstract available.
Oncolytic immunotherapy: where are we clinically?
Hemminki A. Hemminki A. Scientifica (Cairo). 2014;2014:862925. doi: 10.1155/2014/862925. Epub 2014 Jan 16. Scientifica (Cairo). 2014. PMID: 24551478 Free PMC article. Review.
Oncolytic virotherapy trials--letter.
Hemminki A, Oksanen M, Merisalo-Soikkeli M. Hemminki A, et al. Clin Cancer Res. 2013 Aug 15;19(16):4541-2. doi: 10.1158/1078-0432.CCR-13-1471. Clin Cancer Res. 2013. PMID: 23946419 No abstract available.
347 results